Format

Send to

Choose Destination
See comment in PubMed Commons below
J Proteome Res. 2009 May;8(5):2261-72. doi: 10.1021/pr800885j.

Platelet proteome changes associated with diabetes and during platelet storage for transfusion.

Author information

1
Fundamental Science Division, Pacific Northwest National Laboratory, 902 Battelle Boulevard, Richland Washington 99352, USA. david.springer@pnl.gov

Abstract

Human platelets play a key role in hemostasis and thrombosis and have recently emerged as key regulators of inflammation. Platelets stored for transfusion produce pro-thrombotic and pro-inflammatory mediators implicated in adverse transfusion reactions. Correspondingly, these mediators are central players in pathological conditions including cardiovascular disease, the major cause of death in diabetics. In view of this, a mass spectrometry based proteomics study was performed on platelets collected from healthy and type-2 diabetics stored for transfusion. Strikingly, our innovative and sensitive proteomic approach identified 122 proteins that were either up- or down-regulated in type-2 diabetics relative to nondiabetic controls and 117 proteins whose abundances changed during a 5-day storage period. Notably, our studies are the first to characterize the proteome of platelets from diabetics before and after storage for transfusion. These identified differences allow us to formulate new hypotheses and experimentation to improve clinical outcomes by targeting "high risk platelets" that render platelet transfusion less effective or even unsafe.

PMID:
19267493
PMCID:
PMC3017716
DOI:
10.1021/pr800885j
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for American Chemical Society Icon for PubMed Central
    Loading ...
    Support Center